Those conversations rarely fit neatly into a routine consultation
Patients should ask what symptoms need evaluation first, what labs may help, whether peptide therapy is appropriate, what benefits are realistic, what risks are unknown, and how progress would be monitored
N.Ata UarC.AytaB.et al
Semaglutide and tirzepatide are the new peptide weight-loss drug
Without further study, it remains unclear as to whether these are, indeed, true side effects and, if so, how common they may be
These effects involve reductions in visceral fat, adipocyte size, and inflammation, as well as activation of thermogenic pathways such as AMPK/SIRT1 and UCP1 expression